ANIP R&D Expenses

Ani Pharmaceuticals Inc · R&D Expenses

ANIP logo

ANIP R&D Expenses

Latest reported$49.91M
ANIP R&D Expenses ($1.40M → $49.91M)
High-resolution chart · PNG

ANIP r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
51,664,000
44,581,000
34,286,000
22,318,000
11,369,000
16,001,000
19,806,000
15,388,000
9,070,000
2,906,000
2,874,000
2,678,000
1,712,000
16,888,849
44,182,260
39,705,502
13,680,573
15,789,980
4,751,313
3,855,660
6,409,080
9,162,439
3,691,420
4,786,818
2,141,944
1,887,832
660,588
1,400,129
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.